Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene
Objective
To document the phenotype associated with the p.[R74W;V201M;D1270N] and p.P841R mutations of cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Design
Case report.
Setting
Biology and medicine of reproduction in a university hospital.
Patient(s)
A couple in which the man is carrier of the triple mutant p.[R74W;V201M;D1270N] allele in trans to p.P841R mutation and his spouse a heterozygous carrier for the severe p.F508del mutation of the CFTR gene, who became pregnant after intracytoplasmic sperm injection (ICSI) with twins.
Intervention(s)
Genetic counseling; CFTR gene sequencing; ICSI; children's follow-up.
Main Outcome Measure(s)
First report of a male phenotype associated with the p.P841R mutation.
Result(s)
The triple mutant p.[R74W;V201M;D1270N] allele associated with the unknown p.P841R mutations were detected in this man with congenital bilateral absence of the vas deferens, which may presume p.P841R as a severe mutation. After genetic counseling, the couple preferred prenatal diagnosis after ICSI than preimplantation genetic diagnosis, which revealed that the boys were both carriers of p.[R74W;V201M;D1270N] and p.F508del mutations. They are now 4 years old and show normal growth without nutritional deficiency.
Conclusion(s)
This case report documents for the first time a male phenotype associated with the p.P841R mutation and underlines the difficulties in counseling a man with congenital bilateral absence of the vas deferens carrying uncommon mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene before ICSI.
Key Words: CFTR, [p.R74W;p.V201M;p.1270N], p.P841R, genetic counseling, ICSI, CBAVD
To access this article, please choose from the options below
F.B. has nothing to disclose. F.B. has nothing to disclose. M.-C.H. has nothing to disclose. G.G. has nothing to disclose. L.J. has nothing to disclose. I.C. has nothing to disclose.
PII: S0015-0282(08)01166-7
doi:10.1016/j.fertnstert.2008.05.057
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

